Vertex Says Journavx Is US’s Top Branded Oral Pain Drug
Vertex said third-quarter Journavx prescriptions topped 750,000 across hospital and retail settings, up more than 40% sequentially.
Vertex Pharmaceuticals' non-opioid pain drug Journavx becomes the most prescribed branded oral pain medicine in the U.S. as of Aug.. Third-quarter prescriptions topped 750,000 across hospital and retail settings, representing more than 40% sequential growth and quadrupling the 170,000 prescriptions…